Compare EXPD & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPD | WST |
|---|---|---|
| Founded | 1979 | 1923 |
| Country | United States | United States |
| Employees | N/A | 10800 |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 27.7B |
| IPO Year | 1995 | 2004 |
| Metric | EXPD | WST |
|---|---|---|
| Price | $196.24 | $390.87 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 17 |
| Target Price | $181.47 | ★ $412.88 |
| AVG Volume (30 Days) | ★ 957.0K | 422.7K |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.83% | 0.26% |
| EPS Growth | ★ 4.02 | 1.49 |
| EPS | 3.74 | ★ 4.07 |
| Revenue | ★ $6,920,948,000.00 | $2,886,900,000.00 |
| Revenue This Year | $19.65 | $9.79 |
| Revenue Next Year | $0.34 | $6.29 |
| P/E Ratio | ★ $52.17 | $96.68 |
| Revenue Growth | ★ 13.49 | 1.95 |
| 52 Week Low | $117.45 | $223.83 |
| 52 Week High | $200.66 | $397.16 |
| Indicator | EXPD | WST |
|---|---|---|
| Relative Strength Index (RSI) | 57.79 | 67.98 |
| Support Level | $183.83 | $326.40 |
| Resistance Level | $200.66 | N/A |
| Average True Range (ATR) | 3.74 | 8.27 |
| MACD | 0.11 | 1.57 |
| Stochastic Oscillator | 60.86 | 84.96 |
Based in the US, Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. Its offers freight consolidation and forwarding, customs brokerage, warehousing and distribution, purchase order management, vendor consolidation, and numerous other value-added logistics services. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2025, Expeditors derived 36% of consolidated gross revenue from airfreight, 25% from ocean freight, and 39% from customs brokerage and other services.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.